Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function
J. Maspero (Buenos Aires, Argentina), D. Halpin (Exeter, United Kingdom), D. Jackson (London, United Kingdom), N. Hanania (Houston, United States of America), M. Castro (Kansas City, United States of America), C. Domingo (Barcelona, Spain), N. Daizadeh (Cambridge, United States of America), M. Djandji (Cambridge, United States of America), P. Rowe (Bridgewater, United States of America), Y. Deniz (Tarrytown, United States of America)
Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Maspero (Buenos Aires, Argentina), D. Halpin (Exeter, United Kingdom), D. Jackson (London, United Kingdom), N. Hanania (Houston, United States of America), M. Castro (Kansas City, United States of America), C. Domingo (Barcelona, Spain), N. Daizadeh (Cambridge, United States of America), M. Djandji (Cambridge, United States of America), P. Rowe (Bridgewater, United States of America), Y. Deniz (Tarrytown, United States of America). Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function. 5282
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: